Novel protocol for prevention from hepatitis B reactivation following living-donor liver transplantation

被引:0
作者
Izumi, Takuma [1 ]
Toshima, Takeo [1 ]
Itoh, Shinji [1 ]
Yoshiya, Shohei [1 ]
Bekki, Yuki [1 ]
Iseda, Norifumi [1 ]
Tsutsui, Yuriko [1 ]
Toshida, Katsuya [1 ]
Nakayama, Yuki [1 ]
Ishikawa, Takuma [1 ]
Yoshizumi, Tomoharu [1 ]
机构
[1] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, 3-1-1 Maidashi,Higashi Ku, Fukuoka 8128582, Japan
关键词
hepatitis B immunoglobulin; hepatitis B virus; liver transplantation; nucleotide analog; VIRUS RECURRENCE; VIRAL-HEPATITIS; IMMUNE GLOBULIN; LAMIVUDINE; ENTECAVIR; IMMUNOGLOBULIN; PROPHYLAXIS; MONOTHERAPY; EFFICACY; SAFETY;
D O I
10.1111/hepr.14110
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Aim: Reactivation of hepatitis B virus (HBV) after liver transplantation (LT) remains a problem; thus, development of more effective HBV reactivation prophylaxis is desirable. We evaluated the efficacy of a combination of a long-term nucleotide analog (NA), such as entecavir (ETV) or tenofovir alafenamide (TAF), and short-term hepatitis B immunoglobulin (HBIG) in preventing HBV reactivation and compared it with conventional HBV prophylaxis. Methods: Between February 1999 and August 2023, 135 patients underwent living-donor liver transplantation for liver cirrhosis or acute liver failure caused by HBV infection or received an LT from a hepatitis B core antibody-positive donor. Recipients who had undergone LT were classified as being in the first or second era (namely until September 2017 and from October 2017), respectively, and outcomes of prophylaxis against HBV reactivation were compared between the two eras. Results: In the second era, recipients with HBV-related disease or who had received hepatitis B core antibody-positive liver received combination therapy with short-term HBIG and an NA such as TAF and ETV long-term. The duration of HBIG treatment was markedly shorter than in the first era in both categories of patients and HBIG could be discontinued in all cases. Surprisingly, we observed HBV reactivation in the first era, but not in the second era, in both groups. Conclusions: We have established a protocol for prophylaxis against HBV reactivation using a combination of short-term HBIG and long-term NA. This protocol was found to be sufficient to prevent HBV reactivation after LT.
引用
收藏
页码:12 / 21
页数:10
相关论文
共 50 条
[41]   Outcome of Hepatitis B Virus Infection After Living-Donor Liver Transplant: A Single-center Experience Over 20 Years [J].
Nafady-Hego, Hanaa ;
Elgendy, Hamed ;
Nafady, Asmaa ;
Uemoto, Shinji .
EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2016, 14 (02) :207-214
[42]   Risk factors for hepatitis B virus recurrence after living donor liver transplantation: A 17-year experience at a single center [J].
Bae, Sung Kwan ;
Shimoda, Shinji ;
Ikegami, Toru ;
Yoshizumi, Tomoharu ;
Harimoto, Norifumi ;
Itoh, Shinji ;
Soejima, Yuji ;
Uchiyama, Hideaki ;
Shirabe, Ken ;
Maehara, Yoshihiko .
HEPATOLOGY RESEARCH, 2015, 45 (12) :1203-1210
[43]   Intramuscular hepatitis B immunoglobulin (HBIG) and nucleosides for prevention of recurrent hepatitis B following liver transplantation: comparison with other HBIG regimens [J].
Anderson, Robert D. ;
Chinnakotla, Srinath ;
Guo, Linsheng ;
Perrillo, Robert P. ;
Klintmalm, Goeran B. ;
Davis, Gary L. .
CLINICAL TRANSPLANTATION, 2007, 21 (04) :510-517
[44]   Hepatitis B immunoglobulin for prevention of hepatitis B virus infection and recurrence after liver transplantation [J].
Congly, Stephen E. ;
Burak, Kelly W. ;
Coffin, Carla S. .
EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2011, 7 (04) :429-436
[45]   Fulminant hepatitis A infection in second trimester of pregnancy requiring living-donor liver transplantation [J].
Simsek, Yavuz ;
Isik, Burak ;
Karaer, Abdullah ;
Celik, Onder ;
Kutlu, Ramazan ;
Aydin, Nasuhi Engin ;
Yilmaz, Sezai .
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2012, 38 (04) :745-748
[46]   Thrombotic Microangiopathy After Living-Donor Liver Transplantation [J].
Shindoh, J. ;
Sugawara, Y. ;
Akamatsu, N. ;
Kaneko, J. ;
Tamura, S. ;
Yamashiki, N. ;
Aoki, T. ;
Sakamoto, Y. ;
Hasegawa, K. ;
Kokudo, N. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (03) :728-736
[47]   Results of living-donor liver transplantation in Hong Kong [J].
Fan, ST ;
Lo, CM ;
Liu, CL ;
Wei, WI .
CURRENT ISSUES IN LIVER AND SMALL BOWEL TRANSPLANTATION, 2002, 9 :28-42
[48]   Biliary complications in recipients of living-donor liver transplantation [J].
Takatsuki, Mitsuhisa ;
Eguchi, Susumu ;
Kawashita, Yujo ;
Kanematsu, Takashi .
JOURNAL OF HEPATO-BILIARY-PANCREATIC SURGERY, 2006, 13 (06) :497-501
[49]   Living-donor liver transplantation for homozygous familial hypercholesterolemia from a donor with heterozygous hypercholesterolemia [J].
Shirahata, Y ;
Ohkohchi, N ;
Kawagishi, N ;
Syouji, M ;
Tsukamoto, S ;
Sekiguchi, S ;
Koyamada, N ;
Oikawa, S ;
Satomi, S .
TRANSPLANT INTERNATIONAL, 2003, 16 (04) :276-279
[50]   Leukoencephalopathy Syndrome After Living-donor Liver Transplantation [J].
Umeda, Yuzo ;
Matsuda, Hiroaki ;
Sadamori, Hiroshi ;
Shinoura, Susumu ;
Yoshida, Ryuichi ;
Sato, Daisuke ;
Utsumi, Masashi ;
Yagi, Takahito ;
Fujiwara, Toshiyoshi .
EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2011, 9 (02) :139-144